StockWatch
·
Pharmaceuticals
Board Meeting29 Oct 2026, 01:33 pm

Blue Jet Healthcare Board Meeting on Nov 5 to Approve Q2 FY27 Results

AI Summary

Blue Jet Healthcare Ltd has announced that its Board of Directors will convene on Thursday, November 5, 2026. The primary agenda item is to consider and approve the unaudited standalone financial results for the quarter and half-year ended September 30, 2026, along with the limited review report. The company also confirmed that the trading window for designated persons and their immediate relatives will remain closed until 48 hours after the declaration of these financial results, reopening on November 8, 2026. This announcement is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve unaudited standalone financial results for Q2 FY27.
  • Trading window closure extended until 48 hours post-results.
  • Trading window reopens on November 8, 2026.